Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Decreases By 50.0%

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 100 shares, a decline of 50.0% from the September 15th total of 200 shares. Based on an average daily volume of 800 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 800 shares, the short-interest ratio is currently 0.1 days.

BioSyent Price Performance

BioSyent stock opened at $7.98 on Monday. The firm has a fifty day simple moving average of $8.47 and a two-hundred day simple moving average of $8.30. BioSyent has a twelve month low of $6.49 and a twelve month high of $8.85.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.